Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Glycerol-3-phosphate Acyltransferase 1 Promotes Tumor Cell Migration and Poor Survival in Ovarian Carcinoma.

Marchan R, Büttner B, Lambert J, Edlund K, Glaeser I, Blaszkewicz M, Leonhardt G, Marienhoff L, Kaszta D, Anft M, Watzl C, Madjar K, Grinberg M, Rempel E, Hergenröder R, Selinski S, Rahnenführer J, Lesjak MS, Stewart JD, Cadenas C, Hengstler JG.

Cancer Res. 2017 Sep 1;77(17):4589-4601. doi: 10.1158/0008-5472.CAN-16-2065. Epub 2017 Jun 26.

2.

Differential role for PAK1 and PAK4 during the invadopodia lifecycle.

Nicholas NS, Pipili A, Lesjak MS, Wells CM.

Small GTPases. 2017 Mar 16:1-7. doi: 10.1080/21541248.2017.1295830. [Epub ahead of print]

PMID:
28301299
3.

PAK4 suppresses PDZ-RhoGEF activity to drive invadopodia maturation in melanoma cells.

Nicholas NS, Pipili A, Lesjak MS, Ameer-Beg SM, Geh JL, Healy C, MacKenzie Ross AD, Parsons M, Nestle FO, Lacy KE, Wells CM.

Oncotarget. 2016 Oct 25;7(43):70881-70897. doi: 10.18632/oncotarget.12282.

4.

EDI3 links choline metabolism to integrin expression, cell adhesion and spreading.

Lesjak MS, Marchan R, Stewart JD, Rempel E, Rahnenführer J, Hengstler JG.

Cell Adh Migr. 2014;8(5):499-508. doi: 10.4161/cam.29284. Epub 2014 Oct 31.

5.

Choline-releasing glycerophosphodiesterase EDI3 links the tumor metabolome to signaling network activities.

Marchan R, Lesjak MS, Stewart JD, Winter R, Seeliger J, Hengstler JG.

Cell Cycle. 2012 Dec 15;11(24):4499-506. doi: 10.4161/cc.22544. Epub 2012 Oct 31.

6.

Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis.

Stewart JD, Marchan R, Lesjak MS, Lambert J, Hergenroeder R, Ellis JK, Lau CH, Keun HC, Schmitz G, Schiller J, Eibisch M, Hedberg C, Waldmann H, Lausch E, Tanner B, Sehouli J, Sagemueller J, Staude H, Steiner E, Hengstler JG.

Proc Natl Acad Sci U S A. 2012 May 22;109(21):8155-60. doi: 10.1073/pnas.1117654109. Epub 2012 May 8.

7.

Evaluation of a mobile screening service for abdominal aortic aneurysm in Broken Hill, a remote regional centre in far western NSW.

Lesjak MS, Flecknoe-Brown SC, Sidford JR, Payne K, Fletcher JP, Lyle DM.

Aust J Rural Health. 2010 Apr;18(2):72-7. doi: 10.1111/j.1440-1584.2010.01128.x.

PMID:
20398047
8.

Managing environmental lead in Broken Hill: a public health success.

Boreland F, Lesjak MS, Lyle DM.

N S W Public Health Bull. 2008 Sep-Oct;19(9-10):174-9.

PMID:
19091184
9.

Influencing population health performance: feedback from managers, population health staff and clinicians on the NSW Population Health Standards for Area Health Services.

Liddle JL, Jones TC, Lesjak MS, Milat AJ, Lyle DM, Webster EL.

N S W Public Health Bull. 2008 Jul-Aug;19(7-8):117-20.

PMID:
19007542
10.

Alcohol harm and cost at a community level: data from police and health.

Lesjak MS, McMahon GJ, Zanette L.

Rural Remote Health. 2008 Apr-Jun;8(2):878. Epub 2008 Apr 9.

11.

Variation with ageing and degeneration of the serine and cysteine proteinase inhibitors of human articular cartilage.

Ghosh P, Andrews JL, Osborne RA, Lesjak MS.

Agents Actions Suppl. 1986;18:69-81.

PMID:
3088931
12.

Polypeptide proteinase inhibitor from human articular cartilage.

Lesjak MS, Ghosh P.

Biochim Biophys Acta. 1984 Sep 25;789(3):266-77.

PMID:
6383479

Supplemental Content

Loading ...
Support Center